logo-loader

NovaBay Pharmaceuticals, Inc.

Receive alerts
Market:
NYSE
Market Cap:
$17.57 m
Price
0.63 USD
Change
8.55%
52 weeks high
4.02
52 weeks low
0.28

In brief

NovaBay Pharmaceuticals is a clinical stage company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections.